Independent Third-Party Testing

The TADD has undergone thousands of rounds of testing by independent third-parties. We are working hard to get approval for distribution on all of the test reports. In the meantime, we have posted here the reports approved for public distribution. 


Chiron K9

Trials of Training Aid Delivery Device for
Underwater Oil Detection Canine Training

Key Findings:

  • The various studies reported here show that TADDs can be used to train ODCs without exposing the water source to contamination by the target oil sample.

  • Odor molecules, which a trained ODC can identify, pass through the TADD membrane into water or air medium.

  • For effective utilization of the TADD, in-field training, the ODC should be imprinted and trained on the device containing the target, underwater.


University of Pennsylvania

Discrimination of SARS-CoV-2 infected patient
samples by detection dogs: A proof of concept

TADDs were utilized to contain potentially infectious SARS-CoV-2 patient samples:

"After sample inactivation, all samples were stored at a minimum of -20˚C cold storage until aliquoting. Samples from adults or children were combined, but only NP-40-inactivated urine was mixed with NP-40-inactivated urine, heat-inactivated urine was only mixed with heat-inactivated urine and heat-inactivated saliva was only mixed with heat-inactivated saliva. Samples were aliquoted into 400 uL volumes into SciK9 Training Aid Delivery Devices (TADD)."

TADDs were utilized during training in the Tactical Direction Canine Scent Wheel:

"Each wheel contained controls (e.g. SARS-CoV-2 negative samples treated with the same inactivation protocol as targets) as well as distractors (e.g. gloves, empty TADD, garlic on filter paper, SharpieTM marker on filter paper, TADD with coconut flavoring, paperclips, marinade on filter paper, empty cans etc), such that each port contained an odor."


German Armed Forces & University of Veterinary Medicine Hannover GERMANY

Scent dog identification of SARS-CoV-2 infections, similar across different body fluids

TADDs were used to contain infectious clinical samples of SARS-CoV-2 and the TADD membrane was subsequently tested via PCR swab to ensure viral containment. Supplementary Data Table 3 shows the data from the 68 TADDs that were tested and subsequently passed the viral containment tests.